Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Oncotarget 5(23):1241812427 Chaudhary A et al (2012) TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types
Because NAD + reduction is frequently accompanied by impaired mitochondrial performance concomitant to tissue damage and dysfunction [20, 21], tissue NAD + restoration has been proposed as a promising therapeutic target in mitochondria-driven strategies to treat metabolic diseases [19]
moderate or eliminate alcohol intake during NAD+ protocols
They are not for human or veterinary use, consumption, diagnostic procedures, or clinical applications
AOD 9604 is packaged in a sealed laboratory vial designed to help maintain product integrity during shipping and storage
US$ 24.11
US$ 24.43
US$ 25.71
